Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: A Belgian retrospective multicentre study

Dear Editor, We read with great interest the multicenter and retrospective study of Fougerosse et al1 that investigated real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. In the same manner, we conducted the first multicenter study in Belgium aiming to investigate real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. [.]

Verfasser: Benhadou, Farida
Ghislain, Pierre-Dominique
Guiot, Françoise
Willaert, Fabienne
Soenen, Rani
Fierens, Hugues
de la Brassinne, Michel
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Verlag/Hrsg.: Wiley-Blackwell
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28879997
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/230021